-
Symbol
-
GTBP on Nasdaq
-
Investment type
-
Equity / Common Stock
-
Latest Disclosed Shares Owned
-
219,457 shares
-
Security Ownership %
-
9.8%
CYTOVANCE BIOLOGICS INC ownership in GT Biopharma, Inc. Common Stock (GTBP)
17 Oct 2024 - CYTOVANCE BIOLOGICS INC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 219,457 shares of GT Biopharma, Inc. Common Stock (GTBP).
This represents 9.8% ownership of the company.
This is the first filing by CYTOVANCE BIOLOGICS INC disclosing ownership of GT Biopharma, Inc. Common Stock (GTBP).